1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > What’s Driving the In Vitro Diagnostics Industry?--The Road to 2020 and Beyond: Alternative Scenarios of the Future IVD Market--Business-as-Usual, Economic Austerity, Technological Breakthroughs 2015-2020

This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include:
  • To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.

  • To identify key strategic decisions that will have to be made in the future.

  • To enhance corporate ability to develop realistic contingency plans.

  • To prepare executives to accommodate radically different operating climates and reduce surprises.

  • To challenge accepted perceptions of the future diagnostics market.

  • This report is an invaluable strategic planning resource for corporate, marketing and R&D executives. The strategic issues explored in the report include:

    - How will the future reimbursement changes affect individual market segments?
    - Will the industry consolidate, decentralize, or undergo a bimodal transformation?
    - What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers,
    licensing, import and export?
    - How will the future technological advances affect the major market segment?
    - Which companies will enter the market and which will not survive?

    These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.

    Contains 255 pages and 32 tables

     

    Table Of Contents

    What’s Driving the In Vitro Diagnostics Industry?--The Road to 2020 and Beyond: Alternative Scenarios of the Future IVD Market--Business-as-Usual, Economic Austerity, Technological Breakthroughs 2015-2020
    I. INTRODUCTION
    II. EXECUTIVE SUMMARY
    A. BUSINESS-AS-USUAL SCENARIO
    B. ECONOMIC AUSTERITY SCENARIO
    C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
    III. CONCLUSIONS AND RECOMMENDATIONS
    IV.THE SCENARIOS
    A. BUSINESS-AS-USUAL SCENARIO
    1. Business Environment
    a. Health Care Expenditures
    b. Cost-Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
    - PPOs
    - HMOs
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
    - Chronic Illnesses
    - Disease Incidence
    - Susceptibility to Iatrogenesis
    - Multiple Illness Cases
    l. Laboratory Regulations
    m. The FDA Reform
    2. Outlook for the In Vitro Diagnostics Market
    a. Government Regulations
    b. Centralized Testing
    - Hospitals
    - Commercial Laboratories
    - Blood Banks
    - Public Health Laboratories
    c. Decentralized Testing
    - Personal Testing
    - Physician Offices/Group Practices
    - Ancillary Hospital Locations
    - ERs
    - ORs
    - ICUs/CCUs
    - Cancer Clinics
    - Ambulatory Care Centers
    - Surgery Centers
    - Nursing Homes
    - Birth Centers
    3. Strategic Implications
    a. Testing Patterns
    - Test Utilization
    - Pre-Admission Testing
    - Inpatient Testing
    - Outpatient Testing
    4. Market Segments
    a. Chemistry and Immunoassay
    - Introduction
    - Future Situation
    b. Microbiology and Serology
    - Introduction
    - Future Situation
    c. Hematology and Flow Cytometry
    - Introduction
    - Future Situation
    d. Histology and Cytology
    - Introduction
    - Future Situation
    e. Coagulation
    - Introduction
    - Future Situation
    f. Urinalysis
    - Introduction
    - Future Situation
    g. Blood Banking
    - Introduction
    - Future Situation
    5.Technologies
    a. Genomics
    - Introduction
    - Future Situation
    b. Proteomics
    - Introduction
    - Future Situation
    c. DNA Probes
    - Introduction
    - Future Situation
    d. Biochips/Microarrays
    - Introduction
    - Future Situation
    e. Monoclonal Antibodies
    - Introduction
    - Future Situation
    f. Solid Phase Chemistry
    - Introduction
    - Future Situation
    g. Biosensors
    - Introduction
    - Future Situation
    h. Automation and Robotics
    - Introduction
    - Future Situation
    i. Computer-Aided Diagnosis
    - Introduction
    - Future Situation
    6.The New Marketplace
    a. Purchasing Influences
    b. Marketing Strategies
    c. Joint Ventures, Mergers and Licensing
    d. Import-Export
    e. Potential Market Entrants
    f. Who May Not Survive?
    B. ECONOMIC AUSTERITY SCENARIO
    1. Business Environment
    a. Socio-Political Climate
    - Cost-Consciousness
    - Government Actions
    - Three-Tier System
    - Health Rationing
    - Voucher System
    - Health IRA
    b. Hospital Closures
    c. Hospital Utilization
    d. Hospital Reorganization
    e. Physician Regulations
    f. Wellness Programs
    g. Corporate Responses
    h. Academic Research
    2. Outlook for the In Vitro Diagnostics Market
    a. Test Utilization
    - Ordering Practices
    - Documentation
    - Recertification
    b.Technology Regulations
    c. New Laboratory Ventures
    d. Computers
    e. Industrial Medicine
    f. Insurance Companies
    g. Test Volume and Market Size
    3. Strategic Implications
    a. Testing Patterns
    - Pre-Admission Testing
    - Inpatient Testing
    - Outpatient Testing
    b. Market Segments
    - Chemistry and Immunoassay
    - Microbiology and Serology
    - Hematology and Flow Cytometry
    - Histology and Cytology
    - Coagulation
    - Urinalysis
    - Blood Banking
    c.Technologies
    - Genomics
    - Proteomics
    - DNA Probes
    - Biochips/Microarrays
    - Monoclonal Antibodies and Immunoassays
    - Automation and Robotics
    - Solid Phase Chemistry
    - Biosensors
    - Computer-Aided Diagnosis
    d.The New Marketplace
    - Purchasing Influences
    - Marketing Strategies
    - Joint Ventures, Mergers and Licensing
    - Import-Export
    - Potential Market Entrants
    - Who May Not Survive?
    C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
    1. Business Environment
    a. Political/Regulatory Climate
    b. R and D Funding
    c. Industry-Government Relationship
    d. Industry-University Ventures
    e.Technological Environment
    f. Testing Decentralization
    g. Health Care Expenditures
    h. Physician Population
    i. Hospital Indicators
    2. Outlook for the In Vitro Diagnostics Market
    a. Overview
    b. Genomics
    c. Proteomics
    d. DNA and RNA Probes
    e. Biochips/Microarrays
    f. Monoclonal Antibodies
    g. Immunoassays
    h. Information Technology
    i. Laboratory Automation and Robotics
    j. Solid Phase Chemistry
    k. Biosensors
    l. Holography
    m. Pharmaceuticals
    3. Strategic Implications
    a.Testing Patterns
    - Pre-Admission Testing
    - Inpatient Testing
    - Outpatient Testing
    - Test Volume and Market Size
    b. Market Segments
    - Chemistry and Immunoassay
    - Microbiology and Serology
    - Hematology and Flow Cytometry
    - Histology and Cytology
    - Coagulation
    - Urinalysis
    - Blood Banking
    c.The New Marketplace
    - Purchasing Influences
    - Marketing Strategies
    - Joint Ventures, Mergers and Licensing
    - Import-Export
    - Potential Market Entrants
    - Who May Not Survive?
    V.APPENDICES: METHODOLOGY
    A.The Delphi
    B. Cross-Impact Analysis
    C. Substitution Modeling
    Table of Contents
    Executive Summary Table I: Business-As-Usual
    Scenario, Growth Areas in Clinical Laboratory
    Testing
    Executive Summary Table II: Economic Austerity
    Scenario, Growth Areas in Clinical Laboratory
    Testing
    Executive Summary Table III: Technological
    Breakthroughs Scenario, Growth Areas in
    Clinical Laboratory Testing
    Executive Summary Table IV: Market Size by Location
    Executive Summary Table V: Market Size by Laboratory
    Discipline
    Table-1: Business-As-Usual Scenario, Health
    Care Costs by Expenditure Type
    Table-2: Business-As-Usual Scenario, HMO and PPO
    Enrollment
    Table-3: Business-As-Usual Scenario, Selected
    Hospital Statistics
    Table-4: Business-As-Usual Scenario,Total Population
    and Physician Demographics
    Table-5: Business-As-Usual Scenario,Test Volume
    by Location
    Table-6: Business-As-Usual Scenario,Test Distribution
    by Location
    Table-7: Business-As-Usual Scenario, Market Size
    by Location
    Table-8: Business-As-Usual Scenario,Typical
    Pre-Admission Tests
    Table-9: Business-As-Usual Scenario,Test Volume
    by Laboratory Discipline
    Table-10: Business-As-Usual Scenario, Market Size
    By Laboratory Discipline
    Table-11: Economic Austerity Scenario, Selected
    Hospital Statistics
    Table-12: Economic Austerity Scenario,
    HMO and PPO Enrollment
    Table-13: Economic Austerity Scenario,Total Population
    and Physician Demographics
    Table-14: Economic Austerity Scenario, Major
    Categories of Overutilized Tests
    Table-15: Economic Austerity Scenario,
    Test Volume by Location
    Table-16: Economic Austerity Scenario,Test
    Distribution by Location
    Table-17: Economic Austerity Scenario,
    Market Size by Location
    Table-18: Economic Austerity Scenario,Timing
    Requirements for Selected Laboratory Tests
    Table-19: Economic Austerity Scenario,Test Volume
    by Laboratory Discipline
    Table-20: Economic Austerity Scenario, Market Size
    by Laboratory Discipline
    Table-21: Technological Breakthroughs Scenario, HMO
    and PPO Enrollment
    Table-22: Technological Breakthroughs Scenario,Total
    Population and Physician Demographics
    Table-23: Technological Breakthroughs Scenario,
    Selected Hospital Statistics
    Table-24: Technological Breakthroughs Scenario,
    Test Volume by Location
    Table-25: Technological Breakthroughs Scenario,
    Test Distribution by Location
    Table-26: Technological Breakthroughs Scenario,
    Market Size by Location
    Table-27: Technological Breakthroughs Scenario,
    Test Volume by Laboratory Discipline
    Table-28: Technological Breakthroughs Scenario,
    Market Size by Laboratory Discipline


    List of Tables

    View This Report »

    Get Industry Insights. Simply.

    • Latest reports & slideshows with insights from top research analysts
    • 24 Million searchable statistics with tables, figures & datasets
    • More than 10,000 trusted sources
    24/7 Customer Support

    Talk to Ahmad

    +1 718 618 4302

    Purchase Reports From Reputable Market Research Publishers
    2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

    2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

    • $ 47500
    • Industry report
    • October 2016
    • by Venture Planning Group

    This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

    2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

    2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

    • $ 33500
    • Industry report
    • October 2016
    • by Venture Planning Group

    This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

    2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

    2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

    • $ 30000
    • Industry report
    • October 2016
    • by Venture Planning Group

    This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


    ref:plp2016

    Reportlinker.com © Copyright 2016. All rights reserved.

    ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.